SCHEMBL6981600

SCHEMBL6981600

CC(C(=O)O)C(=O)c1ccc(Oc2ccccc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 1/20 0.55
SRD5A2 P31213 4/20 0.53
BCL2 P10415 2/20 0.51
MCL1 Q07820 2/20 0.51
NPY5R Q15761 1/20 0.51
PTGS1 P23219 1/20 0.50
ALDH1A1 P00352 2/20 0.49
RAB9A P51151 2/20 0.47
NPC1 O15118 1/20 0.47
POLB P06746 1/20 0.47
HSP90AA1 P07900 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
ERCC5 P28715 1/20 0.47
FEN1 P39748 1/20 0.47
MAPT P10636 1/20 0.47
HPGD P15428 1/20 0.47
MMP9 P14780 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2625197 0.85 BCL2 (0.61) PARP10SRD5A2BCL2MCL1NPY5R
SCHEMBL649287 0.82 KMT2A (0.55) PTGS1ALDH1A1RAB9ANPC1SMN1; SMN2
SCHEMBL8823334 0.82 KMT2A (0.55) PTGS1ALDH1A1RAB9ANPC1SMN1; SMN2
SCHEMBL11691009 0.82 PARP10 (0.55) PARP10SRD5A2BCL2MCL1NPY5R
SCHEMBL11433567 0.82 PARP10 (0.55) PARP10SRD5A2BCL2MCL1NPY5R
SCHEMBL6554648 0.81 ALDH1A1 (0.64) PARP10ALDH1A1RAB9ANPC1POLB
SCHEMBL11431494 0.81 PARP10 (0.50) PARP10SRD5A2BCL2MCL1NPY5R
Hydrochloric Acid SCHEMBL9642871 0.81 PARP10 (0.58) PARP10SRD5A2BCL2MCL1NPY5R
SCHEMBL6975810 0.79 SMN1; SMN2 (0.57) ALDH1A1RAB9ANPC1POLBSMN1; SMN2
SCHEMBL11367866 0.79 BCL2 (0.52) PARP10SRD5A2BCL2MCL1NPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1109560-B1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMA (US) 2003-08-27 EP disclosed
US-6525050-B1 Inhibit the enzyme aminoimidazole carboxamide ribonucleotide formyl transferase; antiproliferative agents; antitumor, antiinflammatory, antipsoriatic, and/or immunosuppressive AGOURON PHARMACEUTICALS, INC. 2003-02-25 US disclosed
EP-1109560-A4 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMA (US) 2002-04-17 EP disclosed
EP-1109560-A1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 2001-06-27 EP disclosed
WO-2000013688-A1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 2000-03-16 WO disclosed